Hsbc Holdings PLC Decreases Stake in The Clorox Company $CLX

Hsbc Holdings PLC lessened its holdings in shares of The Clorox Company (NYSE:CLX) by 9.7% during the 4th quarter, HoldingsChannel reports. The firm owned 399,264 shares of the company’s stock after selling 43,003 shares during the period. Hsbc Holdings PLC’s holdings in Clorox were worth $40,332,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of CLX. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Clorox by 4.0% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock worth $1,970,000 after buying an additional 514 shares in the last quarter. Woodline Partners LP grew its stake in Clorox by 253.7% during the 1st quarter. Woodline Partners LP now owns 10,407 shares of the company’s stock valued at $1,532,000 after acquiring an additional 7,465 shares in the last quarter. Baird Financial Group Inc. raised its holdings in Clorox by 1.7% in the 2nd quarter. Baird Financial Group Inc. now owns 25,032 shares of the company’s stock valued at $3,006,000 after acquiring an additional 424 shares during the last quarter. Jump Financial LLC raised its holdings in Clorox by 173.5% in the 2nd quarter. Jump Financial LLC now owns 12,491 shares of the company’s stock valued at $1,500,000 after acquiring an additional 7,924 shares during the last quarter. Finally, Bank of Nova Scotia lifted its stake in Clorox by 26.2% in the 2nd quarter. Bank of Nova Scotia now owns 16,141 shares of the company’s stock worth $1,938,000 after purchasing an additional 3,352 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Stock Performance

Clorox stock opened at $92.55 on Wednesday. The firm has a 50 day simple moving average of $95.12 and a 200-day simple moving average of $104.61. The stock has a market cap of $11.19 billion, a price-to-earnings ratio of 15.02, a price-to-earnings-growth ratio of 0.47 and a beta of 0.56. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65. The Clorox Company has a 1-year low of $84.70 and a 1-year high of $132.03.

Clorox (NYSE:CLX) last released its quarterly earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, beating the consensus estimate of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The firm had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same quarter in the previous year, the company earned $1.45 EPS. The business’s revenue for the quarter was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, analysts expect that The Clorox Company will post 5.61 EPS for the current year.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the company. The Goldman Sachs Group restated a “sell” rating and set a $83.00 target price on shares of Clorox in a report on Friday, May 1st. Royal Bank Of Canada reduced their price objective on Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a research report on Thursday, April 9th. Citigroup lowered their price objective on Clorox from $110.00 to $97.00 and set a “neutral” rating on the stock in a research note on Friday, May 1st. Evercore restated an “underperform” rating and issued a $110.00 target price on shares of Clorox in a report on Friday, May 1st. Finally, Zacks Research downgraded Clorox from a “hold” rating to a “strong sell” rating in a research note on Tuesday, May 12th. One investment analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Reduce” and an average price target of $103.40.

Insider Buying and Selling

In other Clorox news, Director Pierre R. Breber bought 5,000 shares of Clorox stock in a transaction on Tuesday, May 5th. The shares were bought at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the transaction, the director directly owned 18,000 shares of the company’s stock, valued at $1,544,760. This trade represents a 38.46% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this link. 0.63% of the stock is owned by corporate insiders.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.